Document is current
Any future updates will be listed below
-
Authors
Yang, Juan https://orcid.org/0000-0001-5028-2227
Liao, Qiaohong
Luo, Kaiwei
Liu, Fengfeng
Zhou, Yonghong https://orcid.org/0000-0002-1242-1764
Zou, Gang
Huang, Wei
Yu, Shuanbao
Wei, Xianglin
Zhou, Jiaxin
Dai, Bingbing
Qiu, Qi
Altmeyer, Ralf
Hu, Hongan
Paireau, Juliette https://orcid.org/0000-0002-5143-6256
Luo, Li
Gao, Lidong
Nikolay, Birgit
Hu, Shixiong
Xing, Weijia
Wu, Peng
van Doorn, H. Rogier
Horby, Peter W. https://orcid.org/0000-0002-9822-1586
Simmonds, Peter
Leung, Gabriel M. https://orcid.org/0000-0002-2503-6283
Cowling, Benjamin J.
Cauchemez, Simon https://orcid.org/0000-0001-9186-4549
Yu, Hongjie https://orcid.org/0000-0002-6335-5648
- License Information
-
More Information
Article History
Received: 8 May 2022
Accepted: 11 November 2022
First Online: 26 November 2022
Competing interests
: H.Y. has received investigator-initiated research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company and SINOVAC Biotech Ltd. None of the research funding is related to this study. All other authors report no competing interests.
